Ledger.Open graph →
SEC Form D · filed April 24, 2014

Immunomic Therapeutics, Inc

Offering
$8.8M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LANCASTER, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Michael Solomon · New York, NYExecAnthony J. De Laurentis · Baltimore, MDDirectorTodd Carter · New York, NYExec · DirectorNathanael Clemensen · PALO ALTO, CADirectorColeman Andrews · PALO ALTO, CAExec · DirectorRmwc Credit Alpha Fund GP, LLC · PALO ALTO, CAExec · Director · PromoterRachel Markus · PALO ALTO, CADirectorMichael Rubenstein · PALO ALTO, CAExec · DirectorLaurence Wainer · Beverly Hills, CAExec · Director · PromoterGreg Schmergel · Woburn, MADirectorDave Fachetti · Woburn, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗